The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
MicroRNA in cardiovascular biology and disease
Open accessAbstract
MicroRNAs (miRNAs) are members of a non-coding RNA family. They act as negative regulators of protein translation by affecting messenger RNA (mRNA) stability; they modulate numerous signaling pathways and cellular processes, and are involved in cell-to-cell communication. Thus, studies on miRNAs offer an opportunity to improve our understanding of complex biological mechanisms. In the cardiovascular system, miRNAs control functions of various cells, such as cardiomyocytes, endothelial cells, smooth muscle cells and fibroblasts. The pivotal role of miRNAs in the cardiovascular system provides a new perspective on the pathophysiology of disorders like myocardial infarction, hypertrophy, fibrosis, heart failure, arrhythmia, inflammation and atherosclerosis. MiRNAs are differentially expressed in diseased tissue and can be released into circulation. Manipulation of miRNA activity may influence the course of a disease. Therefore, miRNAs have become an active field of research for developing new diagnostic and therapeutic tools. This review discusses emerging functions of miRNAs in cardiogenesis, heart regeneration and the pathophysiology of cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Human Cardiac Stem Cell Differentiation Is Regulated by a Mircrine Mechanism
Hosoda, T., Zheng, H., Cabral-da-Silva, M., Sanada, F., Ide-Iwata, N., Ogórek, B., Ferreira-Martins, J., Arranto, C., D'Amario, D., del Monte, F., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.982918 · Cited by 203
RetractedTreatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,204
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
MicroRNAs in Stress Signaling and Human Disease
Mendell, J. T., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.02.005 · Cited by 1,673
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection
Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., Hristov, M., Köppel, T., Jahantigh, M. N., Lutgens, E., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000610 · Cited by 1,334
Pervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Functional screening identifies miRNAs inducing cardiac regeneration
Eulalio, A., Mano, M., Ferro, M. D., Zentilin, L., Sinagra, G., Zacchigna, S., & Giacca, M. (2012) · Nature · doi:10.1038/nature11739 · Cited by 1,029
MicroRNAs: Synthesis, mechanism, function, and recent clinical trials
Wahid, F., Shehzad, A., Khan, T., & Kim, Y. Y. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.06.013 · Cited by 899
Liu, N., Bezprozvannaya, S., Williams, A. H., Qi, X., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Genes & Development · doi:10.1101/gad.1738708 · Cited by 790
MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes
Jayawardena, T. M., Egemnazarov, B., Finch, E. A., Zhang, L., Payne, J. A., Pandya, K., Zhang, Z., Rosenberg, P., Mirotsou, M., & Dzau, V. J. (2012) · Circulation Research · doi:10.1161/circresaha.112.269035 · Cited by 775
Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family
Porrello, E. R., Mahmoud, A. I., Simpson, E., Johnson, B. A., Grinsfelder, D., Canseco, D., Mammen, P. P., Rothermel, B. A., Olson, E. N., & Sadek, H. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208863110 · Cited by 746
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Halkein, J., Tabruyn, S. P., Ricke-Hoch, M., Haghikia, A., Nguyen, N.-Q.-N., Scherr, M., Castermans, K., Malvaux, L., Lambert, V., Thiry, M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64365 · Cited by 499
miR-15 Family Regulates Postnatal Mitotic Arrest of Cardiomyocytes
Porrello, E. R., Johnson, B. A., Aurora, A. B., Simpson, E., Nam, Y.-J., Matkovich, S. J., Dorn, G. W., van Rooij, E., & Olson, E. N. (2011) · Circulation Research · doi:10.1161/circresaha.111.248880 · Cited by 444
Inhibition of miR-25 improves cardiac contractility in the failing heart
Wahlquist, C., Jeong, D., Rojas-Muñoz, A., Kho, C., Lee, A., Mitsuyama, S., van Mil, A., Jin Park, W., Sluijter, J. P. G., Doevendans, P. A. F., et al. (2014) · Nature · doi:10.1038/nature13073 · Cited by 412
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Quiat, D., & Olson, E. N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62876 · Cited by 300
Extracellular/circulating microRNAs and their potential role in cardiovascular disease.
Zhu, H., & Fan, G. (2011) · Europe PMC (PubMed Central) · Cited by 221
Potus, F., Ruffenach, G., Dahou, A., Thebault, C., Breuils-Bonnet, S., Tremblay, È., Nadeau, V., Paradis, R., Graydon, C., Wong, R., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016382 · Cited by 207
Regulation of zebrafish heart regeneration by miR-133
Yin, V. P., Lepilina, A., Smith, A., & Poss, K. D. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.02.018 · Cited by 195
MicroRNAs Expression Profiles in Cardiovascular Diseases
Bronze-da-Rocha, E. (2014) · BioMed Research International · doi:10.1155/2014/985408 · Cited by 172
Functions of MicroRNAs in Cardiovascular Biology and Disease
Hata, A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183737 · Cited by 171
Cell-Based Therapy for Myocardial Ischemia and Infarction: Pathophysiological Mechanisms
Laflamme, M. A., Zbinden, S., Epstein, S. E., & Murry, C. E. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092038 · Cited by 164
MicroRNAs: Small RNAs With Big Effects
Anglicheau, D., Muthukumar, T., & Suthanthiran, M. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e913c2 · Cited by 161
Nishi, H., Ono, K., Iwanaga, Y., Horie, T., Nagao, K., Takemura, G., Kinoshita, M., Kuwabara, Y., Mori, R., Hasegawa, K., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.082610 · Cited by 156
MicroRNAs in Hypertension: Mechanisms and Therapeutic Targets
Bátkai, S., & Thum, T. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0235-6 · Cited by 137
Glass, C. E., & Singla, D. K. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00271.2011 · Cited by 120
Liao, Y., Wang, Y., Guo, Y., Lin, W.-L., Chang, M.-H., & Juo, S. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.069 · Cited by 115
microRNA Therapeutics in Cardiovascular Disease Models
Dangwal, S., & Thum, T. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135957 · Cited by 112
microRNAs in cardiac development and regeneration
Porrello, E. R. (2013) · Clinical Science · doi:10.1042/cs20130011 · Cited by 103
MicroRNA Control of High-Density Lipoprotein Metabolism and Function
Rayner, K. J., & Moore, K. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.300645 · Cited by 101
Mir-24 Regulates Junctophilin-2 Expression in Cardiomyocytes
Xu, M., Wu, H., Li, R.-C., Zhang, H., Wang, M., Tao, J., Feng, X., Guo, Y., Li, S., Lai, S.-T., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.277418 · Cited by 100
MicroRNA miR145 Regulates TGFBR2 Expression and Matrix Synthesis in Vascular Smooth Muscle Cells
Zhao, N., Koenig, S. N., Trask, A. J., Lin, C.-H., Hans, C. P., Garg, V., & Lilly, B. (2014) · Circulation Research · doi:10.1161/circresaha.115.303970 · Cited by 89
Holler, K. L., Hendershot, T. J., Troy, S. E., Vincentz, J. W., Firulli, A. B., & Howard, M. J. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.02.001 · Cited by 69
Mechanisms and therapeutic potential of microRNAs in hypertension
Shi, L., Liao, J., Liu, B., Zeng, F., & Zhang, L. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.007 · Cited by 67
Is miR‐34a a Well‐equipped Swordsman to Conquer Temple of Molecular Oncology?
Farooqı, A. A., Fayyaz, S., Shatynska‐Mytsyk, I., Javed, Z., Jabeen, S., Yaylım, İ., Gasparri, M. L., & Panici, P. B. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12634 · Cited by 37
Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?
Philippen, L. E., Dirkx, E., Wit, J. B. M., Burggraaf, K., Windt, L. J. D., & Martins, P. A. D. C. (2015) · Molecular Therapy · doi:10.1038/mt.2015.133 · Cited by 36
MiRiad Roles for MicroRNAs in Cardiac Development and Regeneration
Fuller, A. M., & Li, Q. (2014) · Cells · doi:10.3390/cells3030724 · Cited by 30
MicroRNAs: powerful regulators and potential diagnostic tools in cardiovascular disease
Klimczak‐Tomaniak, D., Pączek, L., Jażdżewski, K., & Kuch, M. (2015) · Kardiologia Polska · doi:10.5603/kp.a2014.0210 · Cited by 29
Cai, W., Liu, G., Lam, C. K., Florea, S. M., Qian, J., Zhao, W., Pritchard, T. J., Haghighi, K., Lebeche, D., Lu, L. J., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.323 · Cited by 28
Cited by
Recent Advances in miRNA Delivery Systems
Dasgupta, I., & Chatterjee, A. (2021) · Methods and Protocols · doi:10.3390/mps4010010 · Cited by 307
Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles
Bonora, M., Wieckowski, M. R., Sinclair, D. A., Kroemer, G., Pinton, P., & Galluzzi, L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0074-0 · Cited by 294
Kahl, K. G., Stapel, B., & Frieling, H. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.09.004 · Cited by 47
The role of bmp- and fgf signaling modulating mouse proepicardium cell fate
Garcia-Padilla, C., Hernandez-Torres, F., Lozano-Velasco, E., Dueñas, A., Muñoz-Gallardo, M. D. M., Garcia-Valencia, I. S., Palencia-Vincent, L., Aranega, A., & Franco, D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.757781 · Cited by 10
Metadata
- Authors
- Wojciechowska, A., Osiak, A., & Kozar-Kamińska, K.
- Venue
- Advances in Clinical and Experimental Medicine
- Publisher
- Wroclaw Medical University
- Published
- 2017-08-31
- Volume
- 26
- Issue
- 5
- Pages
- 868-874
- ISSN
- 1899-5276 (ISSN-L)
- OpenAlex
- W2753408816
- Cited by
- 418
- References
- 41
- FWCI
- 10.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.